NORMAL AND NEOPLASTIC PROSTATE
NORMAL AND NEOPLASTIC PROSTATE
批准号:
6512520
负责人:
Khalil Ahmed
金额:
$20.78万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1976
资助国家:
美国
项目状态:
已结题
起止时间:
1976-12-01 至 2004-08-31
关键词:
androgen receptor androgens biological signal transduction carcinogenesis casein kinase cell growth regulation disease /disorder model enzyme mechanism genetic manipulation genetically modified animals hormone regulation /control mechanism human tissue immunocytochemistry laboratory rat male neoplastic process neoplastic transformation nuclear matrix polymerase chain reaction prostate prostate neoplasms protein structure function protein transport western blottings
中文摘要
蛋白质磷酸化是一种重要的调控机制。
细胞功能,包括基因组调节和细胞增殖。
因此,对蛋白激酶系统的研究在适当的情况下
实验模型目前引起了人们的浓厚兴趣。对于许多人来说
多年来,该实验室一直专注于蛋白激酶CK2,因为它与
来控制前列腺的生长。CK2是一个多潜能的信使-
独立的丝裂原/酪氨酸激酶。大量证据已经出现,证明了它的
在控制正常细胞生长和增殖方面的作用。谦虚
其活动的失调也与异常生长和
研究表明它参与了肿瘤的发生过程。我们的工作是
前列腺癌组织中CK2的表达与上述结论一致。因此,我们的校长
这项正在进行的研究的假设是蛋白激酶CK2发挥作用
在控制前列腺生长及其失调方面起着重要作用的是
与前列腺瘤有关。本文件中提出的具体目标
CK2生物学知识的更新应用
正常和肿瘤性生长,代表着一种合乎逻辑的发展和
正在进行的研究的扩展。
第一个目标是继续调查所涉及的机制
在生化/生物学方面,CK2的功能与
前列腺癌中CK2的NM状态分析
与格里森等级有关。第二个目标是利用CK2
转基因模型中的信号研究其参与的机制
致癌过程。第三个目标是将CK2信号作为
干扰前列腺生长的潜在部位。
第一个目标的意义在于它对
关于信号调节的基础知识,这对
细胞存活和生长控制。第二个目标的意义
它将导致新的转基因的发展,这将
为研究CK2在脑内的功能作用提供了一个模型
前列腺癌的发生过程,此外,还可能产生一种
研究前列腺癌进展的新模型。这个
第三个目标的意义与其贡献的潜力有关
前列腺癌基因治疗方法的新见解。
总之,这些研究将从根本上提供重要的新的
关于CK2功能活性及其机制的信息
前列腺癌生物学的意义和潜在的治疗方法
目标。
英文摘要
Protein phosphorylation is a significant mechanism in the control of
cellular functions, including genomic regulation and cell proliferation.
Thus, investigations of protein kinase systems in appropriate
experimental models are of intense current interest. For a number of
years, this laboratory has focused on protein kinase CK2 as it relates
to prostatic growth control. CK2 is a multipotential messenger-
independent ser/thr kinase. Considerable evidence has emerged for its
role in the control of normal cell growth and proliferation. Modest
dysregulation in its activity is also related to abnormal growth and
studies suggest its involvement in the oncogenic process. Our work on
CK2 in the prostate accords with these conclusions. Thus, our principal
hypothesis for this ongoing research is that protein kinase CK2 plays
a fundamental role in prostatic growth control and its dysregulation is
associated with prostatic neoplasia. The specific aims set forth in this
renewal application arise from the knowledge gained on CK2 biology in
normal and neoplastic growth and represent a logical progression and
expansion of the ongoing studies.
The first goal is to continue investigations of the mechanisms involved
in biochemical/biological aspects of CK2 function in relation to
prostatic growth, and to analyze the NM status of CK2 in prostate cancer
in relation to the Gleason grade. The second goal is to utilize the CK2
signal in a transgene model to study mechanism of its involvement in the
oncogenic process. The third goal is to target the CK2 signal as a
potential locus for interference of growth in the prostate.
The significance of the first aim relates to its contributions to the
fundamental knowledge on the regulation of a signal that is critical for
cell viability and growth control. The significance of the second aim
is that it will lead to the development of new transgenes which will
serve as a model for investigations of the functional role of CK2 in the
process of oncogenesis in the prostate, and in addition, may yield a
novel model for study of the prostate tumor progression. The
significance of the third aim relates to its potential for contributing
new insights into a gene therapy approach for prostate cancer.
In summary, these studies will provide fundamentally important new
information on the mechanisms of CK2 functional activity as well as its
implications in prostate tumor biology and a potential therapeutic
target.
期刊论文(77)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
--
发表时间:
1982
期刊:
Cellular and molecular biology
影响因子:
1.6
作者:
[Steer,RC, Wilson,MJ, Ahmed,K, Veneziale,CM]
通讯作者:
Veneziale,CM
Modulation of cofactor requirement for the activation of protein kinase C by heparin. Possible effect at the regulatory domain.
肝素调节蛋白激酶 C 激活的辅因子需求。
DOI:
10.1016/0014-5793(91)80533-9
发表时间:
1991
期刊:
FEBS letters
影响因子:
3.5
作者:
[Goueli,SA, Hanten,JA, Ahmed,K]
通讯作者:
Ahmed,K
Role of protein phosphorylation in post-translational regulation of protein B23 during programmed cell death in the prostate gland.
蛋白质磷酸化在前列腺程序性细胞死亡过程中蛋白质 B23 翻译后调节中的作用。
DOI:
10.1074/jbc.270.36.21009
发表时间:
1995
期刊:
The Journal of biological chemistry
影响因子:
--
作者:
[Tawfic,S, Olson,MO, Ahmed,K]
通讯作者:
Ahmed,K
Purification of cytosolic cAMP-independent protein kinases from rat ventral prostate.
从大鼠腹侧前列腺中纯化胞质 cAMP 独立蛋白激酶。
DOI:
10.1016/0020-711x(86)90068-6
发表时间:
1986
期刊:
The International journal of biochemistry
影响因子:
--
作者:
[Goueli,SA, Ferkul,KM, Ahmed,K]
通讯作者:
Ahmed,K
Phosphorylation of the androgen receptor by a nuclear cAMP-independent protein kinase.
雄激素受体被核 cAMP 独立蛋白激酶磷酸化。
DOI:
10.1016/0006-291x(84)90297-3
发表时间:
1984
期刊:
Biochemical and biophysical research communications
影响因子:
3.1
作者:
[Goueli,SA, Holtzman,JL, Ahmed,K]
通讯作者:
Ahmed,K
共 55 条
Dynamics of protein kinase CK2 signaling in prostate cancer pathogenesis
-
批准号:10553127
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2021
-
负责人:Khalil Ahmed
-
依托单位:
Dynamics of protein kinase CK2 signaling in prostate cancer pathogenesis
-
批准号:10341109
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2021
-
负责人:Khalil Ahmed
-
依托单位:
Mechanisms of CK2-regulated prostate cancer survival and death
-
批准号:9032603
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:Khalil Ahmed
-
依托单位:
Modulation of Apoptosis in Prostate Cancer
-
批准号:8458485
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Khalil Ahmed
-
依托单位:
Modulation of Apoptosis in Prostate Cancer
-
批准号:8698327
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Khalil Ahmed
-
依托单位:
Modulation of Apoptosis in Prostate Cancer
-
批准号:8331841
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Khalil Ahmed
-
依托单位:
A Novel Therapeutic Approach for Primary and Metastatic Prostate Cancer
-
批准号:8613312
-
项目类别:
-
资助金额:$28.36万
-
财政年份:2011
-
负责人:Khalil Ahmed
-
依托单位:
A Novel Therapeutic Approach for Primary and Metastatic Prostate Cancer
-
批准号:8119367
-
项目类别:
-
资助金额:$29.65万
-
财政年份:2011
-
负责人:Khalil Ahmed
-
依托单位:
A Novel Therapeutic Approach for Primary and Metastatic Prostate Cancer
-
批准号:8444648
-
项目类别:
-
资助金额:$27.48万
-
财政年份:2011
-
负责人:Khalil Ahmed
-
依托单位:
A Novel Therapeutic Approach for Primary and Metastatic Prostate Cancer
-
批准号:8815090
-
项目类别:
-
资助金额:$29.23万
-
财政年份:2011
-
负责人:Khalil Ahmed
-
依托单位:
A Novel Therapeutic Approach for Primary and Metastatic Prostate Cancer
-
批准号:8236885
-
项目类别:
-
资助金额:$29.35万
-
财政年份:2011
-
负责人:Khalil Ahmed
-
依托单位:
STUDIES OF NORMAL AND NEOPLASTIC PROSTATE
-
批准号:3481697
-
项目类别:
-
资助金额:$13.6万
-
财政年份:1976
-
负责人:Khalil Ahmed
-
依托单位:
STUDIES OF NORMAL AND NEOPLASTIC PROSTATE
-
批准号:3164080
-
项目类别:
-
资助金额:$10.69万
-
财政年份:1976
-
负责人:Khalil Ahmed
-
依托单位:
Studies of Normal and Neoplastic Prostate
-
批准号:6945208
-
项目类别:
-
资助金额:$22.68万
-
财政年份:1976
-
负责人:Khalil Ahmed
-
依托单位:
Studies of Normal and Neoplastic Prostate
-
批准号:6728175
-
项目类别:
-
资助金额:$22.68万
-
财政年份:1976
-
负责人:Khalil Ahmed
-
依托单位:
STUDIES OF NORMAL AND NEOPLASTIC PROSTATE
-
批准号:2086312
-
项目类别:
-
资助金额:$18.64万
-
财政年份:1976
-
负责人:Khalil Ahmed
-
依托单位:
NORMAL AND NEOPLASTIC PROSTATE
-
批准号:3481698
-
项目类别:
-
资助金额:$16.82万
-
财政年份:1976
-
负责人:Khalil Ahmed
-
依托单位:
STUDIES OF NORMAL AND NEOPLASTIC PROSTATE
-
批准号:2086308
-
项目类别:
-
资助金额:$17.57万
-
财政年份:1976
-
负责人:Khalil Ahmed
-
依托单位:
STUDIES OF NORMAL AND NEOPLASTIC PROSTATE
-
批准号:3481696
-
项目类别:
-
资助金额:$13.43万
-
财政年份:1976
-
负责人:Khalil Ahmed
-
依托单位:
STUDIES OF NORMAL AND NEOPLASTIC PROSTATE
-
批准号:3481694
-
项目类别:
-
资助金额:$12.11万
-
财政年份:1976
-
负责人:Khalil Ahmed
-
依托单位:
海外基金